Close
ACHEMA MIDDLE EAST 2026

Motif Bio’s second Phase 3 clinical trial in ABSSSI finishes patient treatment phase

Motif Bio plc ,the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that the last patient has completed the treatment phase in...

Intercept Announces Phase 2 AESOP Trial Evaluating OCA for the Treatment of Patients with PSC

Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, announced that...

Teva and Xenon Announce Phase II Study of Topical TV-45070

Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announce top-line results in a Phase II study of topical TV-45070 in patients with post-herpetic neuralgia...

DelMar Pharmaceuticals Receives Approval from China’s HGRAC to Initiate Phase 2 Clinical Trial

DelMar Pharmaceuticals , a biopharmaceutical company focused on the development of new cancer therapies announced that the HGRAC, has approved the Company's application to...

DelMar Pharmaceuticals Receives IRB Approval for Pivotal Phase 3 Clinical Trial of VAL-083

DelMar Pharmaceuticals  , a biopharmaceutical company focused on the development of new cancer therapies, announced it has received Institutional Review Board (IRB) approval to...

Nutra Pharma and University of Maryland Bioprocess Scale-Up Facility for Phase II Studies

Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing...

Recro Pharma Presents Phase III Bunionectomy Clinical Data For IV Meloxicam

Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings announced the presentation of...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...